Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720200 · ClinicalTrials.gov registry record · Phase 3
ICU Family Communication Study
A Phase 3 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 593
- Enrollment target
NCT00720200: Completed Phase 3 study, sponsored by University of Washington.
NCT00720200 is a Phase 3 study that has completed, run by University of Washington. The registered enrollment target is 593 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00720200, a Phase 3 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 593 participants
- Enrollment target
Study Summary
The purpose of this study is to improve care in the Intensive Care Unit (ICU) by focusing on communication with family members of patients who are too sick to make decisions about their own care while they are in the ICU. The randomized trial will test the efficacy of a communication intervention designed to improve communication between families and clinicians through the use of a facilitator. Outcome evaluation occurs at the level of the individual family with surveys completed by families and clinicians.
Primary Outcome
Family symptoms of depression after the patient dies or is discharged from ICU as assessed by a survey
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Facilitator-Based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 593 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 3 |
What the finished NCT00720200 record still lists
NCT00720200 is an interventional study that assigns participants to a tested intervention. The registered 593 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00720200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00720200 about?
NCT00720200 is a clinical study titled "ICU Family Communication Study". The purpose of this study is to improve care in the Intensive Care Unit (ICU) by focusing on communication with family members of patients who are too sick to make decisions about their own care while they are in the ICU. The randomized trial will test the efficacy of a communication intervention de...
What is the current status of trial NCT00720200?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 593 participants. The study started on 2008-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00720200?
The interventions under investigation include: Usual Care (BEHAVIORAL), Facilitator-Based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00720200?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00720200's enrollment target sits among peer trials
593 643rd of 2000 higher than 1,358 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04701684 · 594 participants · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia